nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—SLC22A7—Glyburide—gestational diabetes	0.513	0.577	CbGbCtD
Zalcitabine—SLC22A6—Glyburide—gestational diabetes	0.218	0.245	CbGbCtD
Zalcitabine—CYP2C9—Glyburide—gestational diabetes	0.1	0.113	CbGbCtD
Zalcitabine—CYP3A4—Glyburide—gestational diabetes	0.0582	0.0655	CbGbCtD
Zalcitabine—Lactic acidosis—Glyburide—gestational diabetes	0.0135	0.135	CcSEcCtD
Zalcitabine—Kidney function abnormal—Glyburide—gestational diabetes	0.00682	0.0683	CcSEcCtD
Zalcitabine—Heartburn—Glyburide—gestational diabetes	0.00479	0.048	CcSEcCtD
Zalcitabine—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00363	0.0363	CcSEcCtD
Zalcitabine—Vascular purpura—Glyburide—gestational diabetes	0.00268	0.0268	CcSEcCtD
Zalcitabine—Deafness—Glyburide—gestational diabetes	0.00268	0.0268	CcSEcCtD
Zalcitabine—Renal failure acute—Glyburide—gestational diabetes	0.00259	0.026	CcSEcCtD
Zalcitabine—Renal impairment—Glyburide—gestational diabetes	0.00251	0.0252	CcSEcCtD
Zalcitabine—Dermatitis bullous—Glyburide—gestational diabetes	0.0025	0.0251	CcSEcCtD
Zalcitabine—Purpura—Glyburide—gestational diabetes	0.00248	0.0249	CcSEcCtD
Zalcitabine—Arthritis—Glyburide—gestational diabetes	0.00246	0.0247	CcSEcCtD
Zalcitabine—Hypoglycaemia—Glyburide—gestational diabetes	0.00245	0.0246	CcSEcCtD
Zalcitabine—Hyponatraemia—Glyburide—gestational diabetes	0.0024	0.0241	CcSEcCtD
Zalcitabine—Abdominal distension—Glyburide—gestational diabetes	0.00208	0.0209	CcSEcCtD
Zalcitabine—Eosinophilia—Glyburide—gestational diabetes	0.00205	0.0205	CcSEcCtD
Zalcitabine—Pancreatitis—Glyburide—gestational diabetes	0.00203	0.0203	CcSEcCtD
Zalcitabine—Sweating increased—Glyburide—gestational diabetes	0.00202	0.0202	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Glyburide—gestational diabetes	0.00189	0.0189	CcSEcCtD
Zalcitabine—Jaundice—Glyburide—gestational diabetes	0.0018	0.018	CcSEcCtD
Zalcitabine—Hepatitis—Glyburide—gestational diabetes	0.00166	0.0166	CcSEcCtD
Zalcitabine—Visual impairment—Glyburide—gestational diabetes	0.0016	0.016	CcSEcCtD
Zalcitabine—Eye disorder—Glyburide—gestational diabetes	0.00155	0.0155	CcSEcCtD
Zalcitabine—Alopecia—Glyburide—gestational diabetes	0.00146	0.0146	CcSEcCtD
Zalcitabine—Vision blurred—Glyburide—gestational diabetes	0.00136	0.0136	CcSEcCtD
Zalcitabine—Tremor—Glyburide—gestational diabetes	0.00135	0.0135	CcSEcCtD
Zalcitabine—Anaemia—Glyburide—gestational diabetes	0.00133	0.0133	CcSEcCtD
Zalcitabine—Leukopenia—Glyburide—gestational diabetes	0.00129	0.0129	CcSEcCtD
Zalcitabine—Convulsion—Glyburide—gestational diabetes	0.00125	0.0125	CcSEcCtD
Zalcitabine—Myalgia—Glyburide—gestational diabetes	0.00123	0.0123	CcSEcCtD
Zalcitabine—Arthralgia—Glyburide—gestational diabetes	0.00123	0.0123	CcSEcCtD
Zalcitabine—SLC29A2—adipose tissue—gestational diabetes	0.00121	0.117	CbGeAlD
Zalcitabine—Confusional state—Glyburide—gestational diabetes	0.00119	0.0119	CcSEcCtD
Zalcitabine—Oedema—Glyburide—gestational diabetes	0.00118	0.0118	CcSEcCtD
Zalcitabine—Shock—Glyburide—gestational diabetes	0.00116	0.0116	CcSEcCtD
Zalcitabine—Thrombocytopenia—Glyburide—gestational diabetes	0.00115	0.0115	CcSEcCtD
Zalcitabine—Hyperhidrosis—Glyburide—gestational diabetes	0.00114	0.0114	CcSEcCtD
Zalcitabine—Anorexia—Glyburide—gestational diabetes	0.00112	0.0112	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00107	0.0107	CcSEcCtD
Zalcitabine—Dyspnoea—Glyburide—gestational diabetes	0.00105	0.0105	CcSEcCtD
Zalcitabine—Dyspepsia—Glyburide—gestational diabetes	0.00104	0.0104	CcSEcCtD
Zalcitabine—Decreased appetite—Glyburide—gestational diabetes	0.00102	0.0102	CcSEcCtD
Zalcitabine—SLC29A2—vagina—gestational diabetes	0.00101	0.0972	CbGeAlD
Zalcitabine—Feeling abnormal—Glyburide—gestational diabetes	0.000969	0.00971	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Glyburide—gestational diabetes	0.000962	0.00963	CcSEcCtD
Zalcitabine—SLC29A1—islet of Langerhans—gestational diabetes	0.000944	0.0909	CbGeAlD
Zalcitabine—Urticaria—Glyburide—gestational diabetes	0.000935	0.00936	CcSEcCtD
Zalcitabine—Abdominal pain—Glyburide—gestational diabetes	0.00093	0.00931	CcSEcCtD
Zalcitabine—DCK—islet of Langerhans—gestational diabetes	0.000901	0.0868	CbGeAlD
Zalcitabine—DCK—embryo—gestational diabetes	0.000872	0.084	CbGeAlD
Zalcitabine—Hypersensitivity—Glyburide—gestational diabetes	0.000867	0.00868	CcSEcCtD
Zalcitabine—Asthenia—Glyburide—gestational diabetes	0.000844	0.00845	CcSEcCtD
Zalcitabine—Pruritus—Glyburide—gestational diabetes	0.000832	0.00833	CcSEcCtD
Zalcitabine—Diarrhoea—Glyburide—gestational diabetes	0.000805	0.00806	CcSEcCtD
Zalcitabine—Vomiting—Glyburide—gestational diabetes	0.000748	0.00749	CcSEcCtD
Zalcitabine—Rash—Glyburide—gestational diabetes	0.000742	0.00743	CcSEcCtD
Zalcitabine—Dermatitis—Glyburide—gestational diabetes	0.000741	0.00742	CcSEcCtD
Zalcitabine—Headache—Glyburide—gestational diabetes	0.000737	0.00738	CcSEcCtD
Zalcitabine—SLC29A1—uterus—gestational diabetes	0.000615	0.0593	CbGeAlD
Zalcitabine—SLC29A1—adipose tissue—gestational diabetes	0.000602	0.058	CbGeAlD
Zalcitabine—DCK—uterus—gestational diabetes	0.000588	0.0566	CbGeAlD
Zalcitabine—DCK—adipose tissue—gestational diabetes	0.000575	0.0554	CbGeAlD
Zalcitabine—SLC29A1—vagina—gestational diabetes	0.0005	0.0482	CbGeAlD
Zalcitabine—DCK—vagina—gestational diabetes	0.000478	0.046	CbGeAlD
Zalcitabine—CYP3A5—islet of Langerhans—gestational diabetes	0.000467	0.045	CbGeAlD
Zalcitabine—SLC29A1—head—gestational diabetes	0.000462	0.0445	CbGeAlD
Zalcitabine—DCK—head—gestational diabetes	0.000441	0.0425	CbGeAlD
Zalcitabine—CYP3A5—adipose tissue—gestational diabetes	0.000298	0.0287	CbGeAlD
Zalcitabine—CYP3A5—vagina—gestational diabetes	0.000247	0.0238	CbGeAlD
Zalcitabine—CYP2D6—head—gestational diabetes	0.000169	0.0163	CbGeAlD
